Results 71 to 80 of about 4,800,081 (359)
Individualization of antiretroviral therapy
Pharmacogenomics and Personalized Medicine, 2011 Rebecca Pavlos, Elizabeth J PhillipsInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, AustraliaAbstract: Antiretroviral therapy (ART) has evolved considerably over the last three decades.
Pavlos R, Phillips EJ
doaj
CD4 LYMPHOCYTE IN HIV / AIDS BEFORE AND AFTER ANTIRETROVIRAL THERAPY
Berkala Kedokteran, 2017 : Human Immunodefficiency Virus (HIV) is a virus that decreases the human immunity system, therefore the infected people become susceptible to any kind of infections.
Rangsang Bagus Prabowo +2 more
doaj +1 more source
Clinical Infectious Diseases, 2016 This meta-analysis provides strong evidence that opioid substitution therapy improves several key outcomes of the HIV care continuum among people who inject drugs, including recruitment onto antiretroviral therapy, retention in care, adherence, and viral
A. Low +14 more
semanticscholar +1 more source
The art of HIV elimination: past and present science [PDF]
, 2015 Introduction: Remarkable strides have been made in controlling the HIV epidemic, although not enough to achieve epidemic control. More recently, interest in biomedical HIV control approaches has increased, but substantial challenges with the HIV cascade ...
de Oliveira, T. +7 more
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims To determine breastmilk concentrations of doravirine via PBPK modelling in combination with a clinical lactation study. As women living with HIV are not able to cease antiretroviral therapy during lactation, it is necessary to establish drug transfer into breastmilk to determine exposure of the infant to antiretroviral drugs and potential risk of ...
Lena van der Wekken‐Pas +3 more
wiley +1 more source
Initiating antiretroviral therapy
Southern African Journal of HIV Medicine, 2005 No abstract available.
Gary Maartens
doaj +1 more source
Personalizing HIV therapy, mission impossible? [PDF]
, 2012 Sustained HIV suppression depends on a number of factors including therapy adherence, management of side effects, viral resistance and individual characteristics of patients and therapeutic settings.
Hentig, Nils von
core +1 more source
Clinical Pharmacology in Drug Development, EarlyView.Abstract Long‐acting cabotegravir is approved for HIV treatment and prevention. To guide management of dosing deviations and interruptions, concentration‐time profiles for monthly and every 2 months regimens were simulated using a population pharmacokinetic (PPK) model.
Kelong Han +3 more
wiley +1 more source
Biochemistry Research International, 2015 The need to develop effective alternative for synthetic indicators is the demand of present-day chemistry. The acid-base indicator properties of Rose (Rosa setigera), Allamanda (Allamanda cathartica), and Hibiscus (Hibiscus rosa-sinensis) flowers were ...
Stanley I. R. Okoduwa +3 more
doaj +1 more source
Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome. [PDF]
PLoS ONE, 2013 We used data from a randomized trial of HIV-tuberculosis co-infected patients in Mozambique to determine the incidence and predictors of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (IRIS) occurring within 12 weeks of ...
Maryline Bonnet +8 more
doaj +1 more source